Stoke Therapeutics Inc (STOK) Unusual Options Activity Today

Checking STOK unusual options activity helps you spot when traders are making outsized bets on Stoke Therapeutics Inc before the broader market catches on. Stoke Therapeutics Inc's unusual options activity flags contracts trading at multiples of their average daily volume, often signaling that informed money is positioning ahead of a catalyst. Use our scanner to monitor STOK unusual options activity today and surface the prints that deserve a second look.

Unusual options flow typically refers to trades where volume vastly exceeds open interest at a given strike, or where total contract volume on a name spikes well above its norm. Watching STOK unusual options flow today can reveal large block trades, sweeps across exchanges, and aggressive directional bets. Tracking STOK unusual options volume across calls and puts helps you separate hedging activity from genuinely speculative positioning, and STOK unusual options flow data becomes especially valuable around earnings, product launches, and macro events.

Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output to design ASOs to precisely upregulate protein expression. Its lead clinical candidate is STK-001, which is in phase I/IIa clinical trial to treat Dravet syndrome, a severe and progressive genetic epilepsy; and STK-002, which is in preclinical stage for the treatment of autosomal dominant optic atrophy. It had entered into a license and collaboration agreement with Acadia Pharmaceuticals Inc.

for the discovery, development, and commercialization of novel RNA-based medicines for the treatment of severe and rare genetic neurodevelopmental diseases of the central nervous system. The company was formerly known as ASOthera Pharmaceuticals, Inc. and changed its name to Stoke Therapeutics, Inc. in May 2016. Stoke Therapeutics, Inc. was incorporated in 2014 and is headquartered in Bedford, Massachusetts.

Catalysts rarely arrive without a footprint, and STOK unusual options activity is often where that footprint shows up first. Our scanner tracks Stoke Therapeutics Inc's unusual options flow in real time, ranks prints by volume-to-open-interest, premium spent, and aggressor side, and separates real conviction from noise. Whether you're looking at STOK unusual options volume on the call side or chasing put sweeps, Stoke Therapeutics Inc's unusual options flow today is one click away, so put it on your radar before the headlines hit.